At the heart of the case is whether efforts to lower health costs through generic competition are undercutting patent protections.
Tina Reed is a Senior Health Care Reporter at Axios. She specializes in pharmaceutical regulation and manufacturing, providing insights into the complexities of the healthcare industry. Tina's work has been featured in notable outlets such as Yahoo News, FierceHealth, and RealClearHealth.
















